Salesforce Als-Con-201 Exam Dumps

The correct answer is A because Salesforce Life Sciences Sample Inventory Management includes a process for fixing unresolved product disbursements. Salesforce Help for managing samples references Fix Unresolved Product Disbursements, and the same Sample Inventory Management area describes inventory operations such as transfers, returns, shipments, assigned batches, and product disbursements as part of the sample lifecycle.

The issue occurs because the rep physically received samples and handed them to an HCP before formally acknowledging the inventory in the system. To preserve inventory integrity, Salesforce cannot simply reduce inventory counts as if the stock were already confirmed in the rep's available inventory. Instead, the system flags the Product Disbursement as unresolved. The rep must first acknowledge the inventory so the system recognizes the received stock, and then use the Resolve Disbursement quick action to complete the reconciliation and finalize the inventory count updates.

Option B is incorrect because the process does not require an admin to manually override an unresolved status in org-wide settings. This is an operational correction handled by the rep through the sample inventory workflow. Option C is also incorrect because forcing a Manual Adjustment would bypass the intended reconciliation process and could weaken auditability. The proper Life Sciences process is to acknowledge the inventory and then resolve the disbursement using the quick action.

=========

The correct answer is A because Account Summarization can use different Cross-Object Field History Graph assignments by org or profile. Salesforce Help for Life Sciences Account Summarization states that administrators can create a Cross-Object Graph for Account Summarization and assign cross-object graphs to an org or profile. Salesforce also describes the Account Summarization workflow as using configured cross-object field history so summaries can include recent and relevant account changes from related objects.

In this case, KAMs see summaries that include Provider Visit and Medical Inquiry records, while field sales reps do not. Both groups have Read access to the objects, so object permission is not the root cause. The difference is most likely profile-based summarization configuration: the graph containing Provider Visit and Medical Inquiry data has been assigned to the KAM profile but not to the field sales rep profile.

Option B is incorrect because Account Summary generation in this scenario is driven by Cross-Object Field History Graph configuration, not membership in a Data 360 segment. Option C is also incorrect because the question explicitly says both user groups have Read access. View All is not the stated requirement for using a graph in summarization. Therefore, the issue is that the Cross-Object Field History Graph is not assigned to the field sales rep profile.

=========

The correct answer is A because Next Best Message uses product-message scoring data at the territory-account-product-message level. Salesforce's Life Sciences Cloud Developer Guide states that Next Best Message provides tailored and relevant messages for each product associated with an account. Salesforce also documents the related scoring object and describes the calculation agent used to calculate the territory account product message score based on various metrics.

The scenario says Cumulus Pharma already has a custom predictive model outside Salesforce. The goal is not to build the model inside Salesforce, but to surface the model's results to reps through the standard Next Best Message capability. Therefore, the external scores and rankings should be loaded into the object that stores ranked product-message recommendations for accounts in territories: Territory Account Product Message Score.

Option B, Visit Recommendation, is not the best answer because the requirement is specifically about product messages for HCPs, not general recommendations tied to a visit. Option C, Score Explainability Info, may support interpretation or explanation of scoring, but it is not the primary object used to load the external product-message score and ranking. To use Next Best Message with external model outputs, the consultant should load the results into Territory Account Product Message Score.

=========

Option A is correct because Account Summarization uses a cross-object graph to define which objects and relationships are included in the generated summary. Salesforce Help states that administrators can create cross-object graphs from a predefined Account Summarization template to provide a complete view of an account and its related objects. This directly matches the requirement to include Account data and related Healthcare Provider and Contact Point Address information in the summary.

The phrase ''historical data'' is also important. Salesforce Account Summarization setup includes configuring history tracking for the fields included in the template, so Agentforce can summarize recent changes from the selected objects and fields. The cross-object graph defines the relationship structure, while field history tracking provides the change history used in the summary.

Option B, Actionable Relationship Center, is not the best answer. Actionable Relationship Center is used to visualize related records and relationships, but the Account Summary configuration specifically relies on cross-object graphs. Option C, Affiliation Alignment Rules, is unrelated because those rules support territory alignment for affiliated accounts, not Account Summary object relationships. Therefore, the consultant should use a Cross-Object Field History Graph to define the Account, Healthcare Provider, Contact Point Address, and related-object structure used by Agentforce Account Summary.

=========

Option C is correct because Salesforce Help identifies ''Access Life Sciences Customer Engagement Agentforce'' as the permission required for Life Sciences Customer Engagement Agentforce capabilities. In the Salesforce Help reference for the Life Sciences ''Generate Healthcare Provider Summary'' action, Salesforce lists the required access as Access Life Sciences Customer Engagement Agentforce. It also notes that, to run flows associated with agent actions, users need the Run Flows app permission or access to the individual flows.

This directly matches the scenario. The Life Sciences Field Sales agent template has already been configured and activated, but the field sales rep cannot use the agent-generated HCP summary capability. That means the issue is not the existence of the agent or the template; it is the user's permission to access the Life Sciences Customer Engagement Agentforce features. Salesforce's Account Summarization permissions documentation also references Access Life Sciences Customer Engagement Agentforce as part of the permission setup for account summarization, alongside standard Life Sciences user permission sets.

Option A, Life Sciences Commercial User, is not specific enough to grant access to these Agentforce capabilities. Option B, Agentforce Service Agent User, relates to Agentforce service use cases and is not the Life Sciences Customer Engagement permission named in the documentation. Therefore, the consultant should assign Access Life Sciences Customer Engagement Agentforce.